Vaccines, Blood & Biologics
Resources for You
Influenza Virus Vaccine for the 2013-2014 Season
FDA's Vaccines and Related Biological Products Advisory Committee (VRBPAC) met in Rockville, Maryland, on February 27, 2013, to select the influenza viruses for the composition of the influenza vaccine for the 2013-2014 U.S. influenza season. During this meeting, the advisory committee reviewed and evaluated the surveillance data related to epidemiology and antigenic characteristics of recent influenza isolates, serological responses to 2012-2013 vaccines, and the availability of candidate strains and reagents.
- an A/California/7/2009 (H1N1)-like virus;
- an (H3N2) virus antigenically like the cell-propagated prototype virus A/Victoria/361/2011;
- a B/Massachusetts/2/2012-like virus.
- a B/Brisbane/60/2008-like virus